Mylan NV(MYL)
15.86
Change: -0.13 (▼ -0.83%)
As of Tue 12/20/2022 12:10 PM% Of Value
Growth
Value Per Share
:
:
:
201.97
0.58
7.8500 (as of 19/11/2020)
NO DATA TO DISPLAY
Fundamentals Data
| Open | 15.86 | Dividend | 521 |
| Close Price | 15.86 | DivYield | 0 % |
| High | 15.855 | Growth | 66.6 M |
| Low | 15.855 | Growth% | 0.58 |
| P/e | 38.071 | Volume | 4,016.0 |
| P/b | 1.58 | Market Capital | 8.1 B |
| Highest High | Lowest Low | ||
| 50 Days Moving Average | 50 Days Moving Average Percentage | 4.109709962169 (as of 06/09/2021 |
| Industry: Major Pharmaceuticals |
Charts for balance Sheet:
Balance Sheet Table: last 5 years
Note: Numbers are estimated, Exact figures can be found in Annual Reports
| Type | Year1 / 2015 | Year2 / 2016 | Year3 / 2017 | Year4 / 2018 | Current Year / 2019 |
| Revenue | 9.4 B | 11.0 B | 11.9 B | 11.4 B | 11.5 B |
| Cap Spending | -360.6 M | -390.4 M | -275.9 M | -252.1 M | -213.2 M |
| Operating Expenses | 2.7 B | 3.9 B | 3.3 B | 3.0 B | 3.1 B |
| Operating Cash Flow | 1.4 B | 701.6 M | 1.4 B | 905.6 M | 715.5 M |
| Free Cash Flow | 1.6 B | 1.6 B | 1.7 B | 2.0 B | 1.5 B |
| Free Cash Flow Per Share | 3.49 | 3.23 | 3.347 | 4.061 | 3.084 |
| Total liabilities | 7.3 B | 15.5 B | 14.7 B | 13.8 B | 12.7 B |
| Total cash | 1.2 B | 998.8 M | 292.1 M | 388.1 M | 475.6 M |
| ROE% | 0.089 | 0.044 | 0.054 | 0.028 | 0.001 |
| Outstanding Shares | 490.6 M | 535.4 M | 514.7 M | 515.9 M | 516.1 M |
| P/E | 24.98 | 50.058 | 30.095 | 38.071 | 573.94 |
| P/S | 2.245 | 2.169 | 1.759 | 1.174 | 0.838 |
| Revenue USD | 9.4 B | 11.0 B | 11.9 B | 11.4 B | 11.5 B |
| NO REPORTS FOR THIS STOCK |
Latest Searches
| Stock | Close Price | %of value | Date |
|---|